📰00Read later0Read MoreA pharma giant is moving past one patent cliff — but another is already loomingUS Top News and Analysis·18 days ago#whoguPZy#cnbc#business#remibrutinib#patients#sales+5 more🧰Tag tools✨Add tagDisappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.15s